Education
About Us
Working with TipRanks
Follow Us
STELLA PHARMA CORPORATION (JP:4888)
:4888
Bnct, ［18F］Fbpa
Thoracic Solid Malignant Tumor
Phase I/II
Enrolling By Invitation
Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
Sep 12, 2024
―
Bnct
Unresectable Angiosarcoma
Phase II
Active Not Recruiting
A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
Oct 27, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does STELLA PHARMA CORPORATION (4888) have in its pipeline
4888 is currently developing the following drugs: Bnct, ［18F］Fbpa, Bnct. These drug candidates are in various stages of clinical development as the company works toward FDA approval.